Mikael Dolsten - Sep 9, 2024 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
Director
Signature
/s/ Martin Wilson, as attorney-in-fact for Mikael Dolsten
Stock symbol
RCKT
Transactions as of
Sep 9, 2024
Transactions value $
$0
Form type
4
Date filed
9/11/2024, 04:07 PM
Previous filing
Sep 11, 2024
Next filing
Sep 16, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RCKT Stock Option (Right to Buy) Award $0 +27.5K $0.00 27.5K Sep 9, 2024 Common Stock 27.5K $19.73 Direct F1
transaction RCKT Stock Option (Right to Buy) Award $0 +23K $0.00 23K Sep 9, 2024 Common Stock 23K $19.73 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase a total of 27,545 shares of the Issuer's common stock, which will vest in equal monthly installments over a three-year period, such that all of the shares underlying this option will be fully vested on September 9, 2027.
F2 This option represents a right to purchase a total of 22,988 shares of the Issuer's common stock, which will fully vest on September 9, 2025.